Risk factors for neuroblastoma;Factores de riesgo para el neuroblastoma

Anales de Pediatria

Volumn 63, Issue 1, 2005, Pages 50-60

  Ferris I Tortajada J ^a   Ortega Garcia J A ^a   Garcia I Castell J ^b   Lopez Andreu J A ^a   Berbel Tornero, O ^a   Crehua Gaudiza E ^a  

^a HOSPITAL INFANTIL LA FE   (Spain)

^b HOSPITAL DE SAGUNTO   (Spain)

Author keywords

Breastfeeding; Epidemiology; Etiology; Neuroblastoma; Risk factors

Indexed keywords

BREAST FEEDING; CANCER GROWTH; CANCER LOCALIZATION; CANCER REGRESSION; CHILD PARENT RELATION; CLINICAL TRIAL; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GANGLIONEUROMA; GEOGRAPHIC DISTRIBUTION; GESTATIONAL AGE; HEREDITY; HUMAN; INFECTION RISK; MATERNAL WELFARE; METASTASIS; NEUROBLASTOMA; OCCUPATIONAL EXPOSURE; PARENT; PATHOGENESIS; PERINATAL PERIOD; PREGNANCY; REVIEW; RISK FACTOR; SOCIAL ASPECT; SOCIOECONOMICS; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION;

EID: 23044453922     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13076768     Document Type: Article

References (59)

1. Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, et al, editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program NIH Pub N.° 99-4649. Betsheda, MD, 1999.
2. a ed. Madrid: Ergón; 1997. p. 501-20.
3. Brodeur GM, Maris JM. Neuroblastoma. En: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 4th ed. Philadelphia: Lippincott-Williams and Wilkins; 2002: p. 895-937.
4. Izbicki T, Mazur J, Izbicki E. Epidemiology and etiology of neuroblastoma: An overview. Anticancer Res. 2003;23:755-60.
5. Mc Conville CM, Forsyth J. Neuroblastoma - a developmental perspectiva. Cancer Lett. 2003;197:3-9.
6. Reaman GH. Pediatric oncology: Principles and practice. En: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC Jr, Gansler TS, Holland JF, et al, editors. Cancer Medicine. 6th ed. Hamilton: Decker; 2003. p. 2291-3.
7. Francis NJ, Landis SC. Cellular and molecular determinants of sympathetic neuron development. Annu Rev Neurosci. 1999;22:541-66.
8. Tucker GR. Adrenocoticotropic hormona in the aetiology and regresión of neuroblastoma. Med Hypothesis. 2002;59:117-28.
9. Brodeur GM. Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer. 2003;3:203-16.
10. Carlsen NLT. How frequence is spontaneous regression of neuroblastoma? Implications for screening. Brit J Cancer. 1990;61:441-6.
11. Van Noesel MM, Vergsteeg R. Pediatric neuroblastoma: Genetic and epigenetic "danse macabre". Gene. 2004;325:1-5.
12. Westermann F, Schaw M. Genetic parameters of neuroblastomas. Cancer Lett. 2002;184:127-47.
13. Romani M, Tonini GP, Banelli B, Allemanni G, Mazzocco K, Scaruffi P, et al. Biological and clinical role of p73 in neuroblastoma. Cancer Lett. 2003;197:111-7.
14. Kushner BH, Gilbert F, Helson L. Familial neuroblastoma. Cancer. 1986;57:1887-95.
15. Ferrís i Tortajada J, Garcia i Castell J, López Andreu JA, Pellicer Porres C. Factores genéticos asociados a cánceres pediátricos. An Esp Pediatr. 1999;50:4-13.
16. Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, et al. Molecular genetic analysis of familial neuroblastoma. Eur J Cancer. 1997;33:1923-8.
17. Litte J. Epidemilogy of Childhood Cancer. Internacional Agency for Research on Cancer. World Health Organization. Lyon: IARC Scientific Publications; 1999. No. 149.
18. Parkin DM, Kramárová E, Draper GJ, Masuyer E, Michaelis J, Neglia J, et al. International Incidence of Childhood Cancer, Vol II. International Agency for Research on Cancer. World Health Organization. Lyon: IARC Scientific Publications. 1999. No. 144.
19. Stiller CA, Parkin DM. Internacional variations in the incidente of neuroblastoma. Int J Cancer. 1992;52:538-43.
20. Carlsen NLT. Neuroblastomas presenting in the first year of life: Epidemiological differences from those presenting at older ages. Cancer Detect Prev. 1996;20:251-61.
21. Michalek AM, Buck GM, Nasca PC, Freedman AN, Baptiste MS, Mahoney MC. Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol. 1996;143:996-1001.
22. Cinatl J Jr, Cinatl J, Vogel JU, Kotchetkov R, Driever PH, Kabickova H, et al. Persistent human cytomegalovirus infection induces drug resistence and alteration of programmed cell death in human neuroblastoma cells. Cancer Res. 1998;58:367-72.
23. Flaegstad T, Andresen PA, Johnsen JI, Asomani SK, Jorgensen GE, Vignarajan S, et al. A possible contributory role of BK virus infection in neuroblastoma development. Cancer Res. 1999;59:1160-3.
24. Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997;70:130-9.
25. Olshan AF, De Roos AJ, Teschke K, Neglia JP, Stram BH, Castleberry RP. Neuroblastoma and parenteral occupation. Cancer Causes Control. 1999;10:539-49.
26. Spitz MR, Johnson CC. Neuroblastoma and parenteral occupation. Am J Epidemiol. 1985;121:924-9.
27. De Roos AJ, Teschke K, Savitz DA, Poole C, Grufferman S, Pollock BH, et al. Parental occupational exposure to electromagnetic fields and radiation and incidence of neuroblastoma in offspring. Epidemiology. 2001;12:508-17.
28. Colt JS, Blair A. Parental occupational exposures and risk of childhood cancer. Environ Health Perspect. 1998;106 Supl 3:909-25.
29. Feychting M, Plato N, Nise G, Ahlbom A. Paternal occupational exposures and childhood cancer. Environ Health Perspect. 2001;109:193-6.
30. Bunin GR, Ward E, Kramer S, Rhee CA, Meadows AT. Neuroblastoma and parental occupation. Am J Epidemiol. 1990;131:776-80.
31. Kerr MA, Nasca PC, Mundt KA, Michalek AM, Baptiste MS, Mahoney MC. Parental occupational exposures and risk of neuroblastoma: A case-control study (United States). Cancer Causes Control. 2000;11:635-43.
32. De Roos AJ, Poole C, Teschke K, Olshan AF. An application of hierarchical regression in the investigation of multiple paternal occupational exposures and neuroblastoma in offspring. Am J Ind Med. 2001;39:477-86.
33. Olshan AF, De Roos AJ, Teschke K, Neglia JP, Stram DO, Pollock BH, et al. Neuroblastoma and parental occupation. Cancer Causes Control. 1999;10:539-49.
34. De Roos AJ, Olshan AF, Teschke K, Poole C, Savitz DA, Blatt J, et al. Parental occupational exposures to chemicals and incidente of neuroblastoma in offspring. Am J Epidemiol. 2001;154:106-14.
35. Kramer S, Ward E, Meadows AT, Malone KE. Medical and drug risk factors associated with neuroblastoma: A case-control study. J Natl Cancer Inst. 1987;78:797-804.
36. Schartzbaum JA. Influence of mother's prenatal drug consumption on risk of neuroblastoma in the child. Am J Epidemiol. 1992;135:1358-67.
37. Mandel M, Toren A, Rechavi G, Dor J, Ben-Bassat I, Neumann Y. Hormonal treatment in pregnanacy: A possible risk for neuroblastoma. Med Pediatr Oncol. 1994;23:133-5.
38. Schüz J, Kaletsch U, Meinert R, Kaatsch P, Spix C, Michaelis J. Risk factors for neuroblastoma at different stages of disease. Results from a population-based case-control study in Germany. J Clin Epidemiol. 2001;54:702-9.
39. Allen RW Jr, Ogden B, Bentley FL, Jung AC. Fetal hydantoin syndrome, neuroblastoma, and hemorrhagic disease in a neonate. JAMA. 1980;244:1464-5.
40. Cook MN, Olshan AF, Guess HA, Savitz DA, Poole C, Blatt J, et al. Maternal medication use and neuroblastoma in offspring. Am J Epidemiol. 2004;159:721-31.
41. Gouveia-Vigeant T, Tickner J. Toxic chemicals and childhood cancer: A review of the evidence. Publication of the Lowell Center for Sustainable Production. Amherst: Lowell. University of Massachussets, 2003.
42. Buck GM, Michalek AM, Chen CJ, Nasca PC, Baptiste MS. Perinatal factors and risk of neuroblastoma. Paediatr Perinat Epidemiol. 2001;15:47-53.
43. Hamrick SEG, Olshan AF, Neglia JP, Pollock BH. Association of pregnancy history and birth characteristics with neuroblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. Paeditr Perinat Epidemiol. 2001;15:328-37.
44. Neglia JP, Smithson WA, Gunderson P, King FL, Singer LJ, Robison LL. Prenatal and perinatal risk factors for neuroblastoma. A case-control study. Cancer. 1988;61:2202-6.
45. Daniels JL, Olshan AF, Pollock BH, Shah NR, Stram DO. Breast-feeding and neuroblastoma, USA and Canada. Cancer Causes Control. 2002;13:401-5.
46. Davis MK. Review of the evidence for an association between infant feeding and childhood cancer. Int J Cancer Suppl. 1998;11:29-33.
47. Shu XO, Linet MS, Steinbuch M, Wen WQ, Buckley JD, Neglia JP, et al. Breast-feeding and risk of childhood acute leukemia. J Natl Cancer Inst. 1999;91:1765-72.
48. Infante-Rivard C, Fortier I, Olson E. Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia. Br J Cancer. 2000;83:1559-64.
49. Olshan AF, Smith JC, Bondy ML, Neglia JP, Pollock BH. Maternal vitamin use and reduced risk of neuroblastoma. Epidemiology. 2002;13:575-80.
50. Yu SM, Keppel KG, Sing GK, Kessel W. Preconceptional and prenatal multivitamin-mineral supplement use in the 1988 National Maternal and Infant Health Survey. Am J Public Health. 1996;86:240-2.
51. Bailey LB, Rampersaud GC, Kauwell GPA. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: Evolving science. J Nutr. 2003;133:1961-8.
52. 12 in health and disease. Nutr Rev. 2004;62:3-12.
53. Reynolds CP. Differentiating agents in pediatric malignancies: Retinoids in neuroblastoma. Curr Oncol Rep. 2000;2:511-8.
54. Preston-Martin S, Pogoda JM, Mueller BA, Lubin F, Holly EA, Filippini G, et al. Prenatal vitamin supplementation and risk of childhood brain tumors. Int J Cancer Suppl. 1998;11:17-22.
55. Thompson JR, Gerald PF, Willoughby ML, Armstrong BK. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: A case-control study. Lancet. 2001;358:1935-40.
56. Ferrís i Tortajada J, Ortega García JA, López Ibor B. La etiología y la prevención del cáncer pediátrico. An Pediatr. 2004;61:1-4.
57. A European Environment and Health Strategy. Commission to the Council, the European Parlament and the European Economic and Council Committee. Brussels, 11-6-2003. Disponible en: http://europa.eu.int/eur-lex/en/com/cnc/ 2003/com2003_0338en01.pdf
58. World Health Organization. Healthy Environments for Children Alliance. Disponible en: http://www.who.int/heca/en/
59. Ferrís i Tortajada J, Ortega García JA, Marco Macián A, García i Castell J. Medio ambiente y cáncer pediátrico. An Pediatr (Barc). 2004;61:42-50.